Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Oral Oncol. 2016 Dec 3;64:44–51. doi: 10.1016/j.oraloncology.2016.11.015

Table 2.

Difference in dosimetry between ORN site and contralateral site (N = 39)

Dose measurement Median Difference (IQR) Mean Difference (95% CI) P
Maximum dose(Gy) 6.1 (.8, 23.9) 13.2 (7.4, 18.9) 0.000004
Mean dose(Gy) 13.5 (1.2, 28.4) 14.6 (8.3, 20.9) 0.000012

P-values calculated with paired Wilcoxon tests.